HOME  >  Pipelines

GM103

GM103

Indication : Metastatic liver and lung cancer

Development stage : Preparing phase I clinical trial

Highly tumor-specific GM oncolytic virus that is capable of inducing a strong antitumor immune response and antiangiogenic effect
  • - Inhibits neo-angiogenesis
  • - Inhibits proliferation and metastasis of cancer cells
  • - Induces tumor-specific immune response
  • - Overcomes tumor-induced immunosuppression
TOP